MedTrace Logo

Effects of COVID 19 Vaccine on Egyptian Population

NCT04809948 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2021-03-24

No results posted yet for this study

Summary

The aim of this study is to identify adverse events following vaccination by the COVID-19 vaccine by evaluating adverse side effects, hematological values; immunogenicity in the Egyptian candidates in response to COVID-19 vaccine, summarizing the which may occur following administration of COVID-19 vaccine.

Conditions

  • COVID 19 Vaccine

Interventions

BIOLOGICAL

viral vector vaccine

AstraZeneca vaccine

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2021-09-01
Completion
2021-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04809948 on ClinicalTrials.gov